Earningsreport

Q2/2023 6/30/2023 EPS -0.320 ZacksConsensus -0.440 ActVsEst 0.120 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors